China's NMPA Releases Cosmetic Registration Optimization Measures, Encourages Global First Launches
China's National Medical Products Administration issued eight optimization measures on July 29 for cosmetic registration and filing, effective immediately. The measures encourage international new products to debut in China first by allowing a declarative statement in lieu of overseas market approval proof. China, the world's largest cosmetic market, saw total transaction value reach RMB 1.104245 trillion in 2025, up 2.83% year-on-year, and RMB 611.41 billion in the first half of 2026, up 4.35%. The cosmetic concept index rose 8.78% in July, with Pian Zai Huang and Aimeike surging 26.1% and 23.62% respectively.
The National Medical Products Administration (NMPA) issued on July 29 the Announcement on Matters Concerning Cosmetic Registration and Filing, introducing eight optimization measures that took effect from the date of issuance. Among them, the institutional design encouraging international new cosmetic products to debut in China has drawn significant attention. According to the announcement, for overseas new products that debut or launch simultaneously in China, registrants and filers may submit a declarative statement, exempting them from providing proof of marketing or sale in the country or region of origin. This measure aims to shorten product launch cycles, reduce corporate compliance costs, and promote high-quality development of the cosmetic industry.
China has become the world's largest cosmetic consumer market. According to data from the China Association of Fragrance, Flavour and Cosmetic Industries, the industry's full-channel transaction value reached RMB 1.104245 trillion in 2025, exceeding RMB 1.1 trillion for the first time, up 2.83% year-on-year. In the first half of 2026, total full-channel transaction value was RMB 611.41 billion, up 4.35% year-on-year. Of this, online channel transaction value was approximately RMB 380.887 billion, up 5.74%, while offline channel transaction value was approximately RMB 230.519 billion, up 2.13%.
In July, the cosmetic concept index rose 8.78%, with notable gains among constituent stocks. Pian Zai Huang and Aimeike rose 26.1% and 23.62% respectively, while Lafang, Mayinglong, Shanghai Jahwa, and Liren Lizhuang each posted cumulative gains exceeding 10%. Pian Zai Huang Cosmetics, which owns several skincare and personal care brands, reported cosmetic business revenue of RMB 567 million in 2025 with a gross margin of 57.54%. Shanghai Jahwa, whose main brands include Liushen and Yuze, reported daily-use cosmetic business revenue of RMB 6.314 billion in 2025, up 11.26% year-on-year, with a gross margin of 62.59%.
As of July 30, five cosmetic concept stocks have pre-announced their semi-annual results for 2026.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Cosmetics, with intensity 70/100 and 85% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.